Lanthanum carbonate
At a glance
- Drug Originator Genzyme Corporation
- Drug Licenced by Bayer Yakuhin; Swedish Orphan Biovitrum; Takeda
- Drug Class Hyperphosphataemia therapies; Lanthanoid series elements; Small molecules
- Mechanism of Action Phosphate binding modulators
- USA Patent Applicants TAKEDA PHARMS USA
- USA Patents 7
- NDAs 2
- International Patents 14

Disclaimer